SCHEMBL1162745

SCHEMBL1162745

CC(=O)OC1(NC(=O)OCc2ccccc2)CCC(F)(F)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
CTSB P07858 3/20 0.46
CTSS P25774 3/20 0.46
CTSL P07711 2/20 0.46
CTSK P43235 2/20 0.44
GAA P10253 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KDM1A O60341 1/20 0.41
MAOB P27338 1/20 0.41
ELANE P08246 1/20 0.41
DPP4 P27487 1/20 0.41
KCNH2 Q12809 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28293240 0.89 ALDH1A1 (0.49) ALDH1A1CTSBCTSSCTSLCTSK
SCHEMBL2746328 0.79 CTSS (0.52) ALDH1A1CTSBCTSSCTSLCTSK
SCHEMBL1162743 0.77 CTSL (0.45) ALDH1A1CTSBCTSSCTSLGAA
SCHEMBL9639481 0.76 CTSS (0.55) ALDH1A1CTSBCTSSCTSLCTSK
SCHEMBL336592 0.76 CTSL (0.48) ALDH1A1CTSBCTSSCTSLGAA
SCHEMBL29230112 0.75 CA12 (0.49) ALDH1A1CTSBCTSSCTSLGAA
SCHEMBL29053942 0.74 CA12 (0.48) ALDH1A1CTSBCTSSCTSLGAA
SCHEMBL14751533 0.74 CTSS (0.58) ALDH1A1CTSBCTSSCTSLCTSK
SCHEMBL14743992 0.74 CTSL (0.54) ALDH1A1CTSBCTSSCTSLGAA
SCHEMBL28744973 0.73 CTSS (0.52) ALDH1A1CTSBCTSSCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011016576-A1 ALANINE DERIVATIVES AS INHIBITORS OF APOPTOSIS PROTEINS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-02-10 WO disclosed